New therapeutic approaches for non-muscle invasive bladder cancer (NMIBC): intravesical use of oncotherad biological response modifier and its association with platelet-rich plasma (PRP)
2018 ◽
Vol 25
(16)
◽
pp. 5082-5093
◽
Keyword(s):